Evidence map›Paper›PMID 26494215›Full record

ReviewDiabetes2015

β-Cell MicroRNAs: Small but Powerful.

Stephen R Filios, Anath Shalev

Open access · bronzeAbstract readReview
In one paragraph

Review in Diabetes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Glycemia-Induced miRNA Changes: A Review.International journal of molecular sciences · 2023
    Review
  8. Article
  9. The Role of Forkhead Box O in Pathogenesis and Therapy of Diabetes Mellitus.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stephen R FiliosComprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, The University of Alabama at Birmingham, Birmingham, AL.
Anath ShalevComprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, The University of Alabama at Birmingham, Birmingham, AL shalev@uab.edu.
University of Alabama at Birmingham · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASSR01DK078752 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI SHALEV, ANATH · 2008 to 2021
$4.4M
Targeting TXNIP to enhance beta cell mass in T1DUC4DK104204 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SHALEV, ANATH · 2014 to 2014
$1.1M
NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK078752NIDDK NIH HHS R01DK078752NIDDK NIH HHS UC4 DK104204NIDDK NIH HHS UC4DK104204
6 · The paper itself

Abstract

Noncoding RNA and especially microRNAs (miRs) have emerged as important regulators of key processes in cell biology, including development, differentiation, and survival. Currently, over 2,500 mature miRs have been reported in humans, and considering that each miR has multiple targets, the number of genes and pathways potentially affected is huge. Not surprisingly, many miRs have also been implicated in diabetes, and more recently, some have been discovered to play important roles in the pancreatic islet, including β-cell function, proliferation, and survival. The goal of this Perspective is to offer an overview of this rapidly evolving field and the miRs involved, reveal novel networks of β-cell miR signaling, and provide an outlook of the opportunities and challenges ahead.

Indexed as

Cell DifferentiationCell ProliferationCell SurvivalDiabetes MellitusHumansInsulin-Secreting CellsMicroRNAsSignal TransductionMicroRNAs

Identifiers

PMID26494215
PMCPMC4613982
OpenAlexW2097687832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.